Methods and apparatuses for assembly of a pericardial prosthetic heart valve

Information

  • Patent Grant
  • 8312825
  • Patent Number
    8,312,825
  • Date Filed
    Thursday, April 16, 2009
    15 years ago
  • Date Issued
    Tuesday, November 20, 2012
    11 years ago
Abstract
A method of assembling a prosthetic valve using sheets of material, such as pericardium material, polymer or bioengineered film, or other material. The method provides an accurate and repeatable system of making pericardial valves in which sheets or pieces of material are held securely in place relative to each other throughout the steps of assembling the valve. In addition, methods of the present invention include maintaining consistent alignment of the fixtures and pericardium material throughout the valve assembly process and utilize features that make the tooling components easy to assemble and handle. Certain aspects of the invention can be used to help establish a repeatable sewing and cutting technique for creating a pattern shape for valve leaflets, establishing stitch lengths, and determining the exact placement of stitches.
Description
TECHNICAL FIELD

The present invention relates generally to treatment of cardiac heart disease. More particularly, the present invention relates to implantable valve prostheses for implantation into the cardiac system.


BACKGROUND

All four of the valves in the heart are passive structures in that they do not themselves expend any energy and do not perform any active contractile function. They consist of moveable “leaflets” that open and close in response to differential pressures on either side of the valve. The problems that can develop with valves can generally be classified into two categories: (1) stenosis, in which a valve does not open properly, and (2) insufficiency (also called regurgitation), in which a valve does not close properly. Stenosis and insufficiency may occur concomitantly in the same valve or in different valves. Both of these abnormalities increase the workload placed on the heart. The severity of this increased stress on the heart and the patient, and the heart's ability to adapt to it, determine the treatment options that can be pursued. In some cases, medication can be sufficient to treat the patient, which is the preferred method of treatment; however, in many cases defective valves have to be repaired or completely replaced in order for the patient to live a normal life.


The two general categories of valves that are available for implantation into the cardiac system are mechanical valves and bioprosthetic or tissue valves Mechanical valves have been used for many years and encompass a wide variety of designs that accommodate the blood flow requirements of the particular location where they will be implanted. Although the materials and design features of these valves are continuously being improved, they do increase the risk of clotting in the blood stream, which can lead to a heart attack or stroke. Thus, mechanical valve recipients must take anti-coagulant drugs for life to lessen the potential for blood clot formation. Further, mechanical valves can sometimes suffer from structural problems that may force the patient to have additional surgeries for further valve replacement.


Bioprosthetic valves, which are also referred to as prosthetic valves, generally include both human tissue valves and animal tissue valves. The designs of these bioprosthetic valves are typically relatively similar to the design of the natural valves of the patient and advantageously do not require the use of long-term anti-coagulant drugs. Human tissue valves are typically not available in large quantities, however, since they must be removed from deceased persons who have elected organ donation. On the other hand, animal tissue valves are more widely available for the patients who require valve replacement due to the large numbers of animals routinely processed at meat processing facilities, for example. The most common types of animal tissue valves used include porcine aortic valves, and bovine and porcine pericardial valves, some of which are incorporated with a stent before being implanted in a patient. In the case of pericardial valves, the use of pericardial material to design and make the heart valves provides a much larger range of options than is available when using only harvested valves.


In order to manufacture these pericardial valves, a number of steps must be performed on one or more pieces of pericardium material, where this work is typically done by highly-skilled operators in a controlled environment. Even under these conditions, however, there is concern that minor variations in the valves can occur due to slight differences in the techniques used by individual operators and the variability of materials used. In order to minimize these variations, there is a need to provide reproducible and simple tooling and methods for manufacturing pericardial valves.


SUMMARY

The present invention is directed to prosthetic cardiac valves and methods of making such valves. In one embodiment, the invention involves methods and tooling for making valves using sheets or pieces of material, such as pericardium material, polymer or bioengineered film, or other material. The tooling and processes provide an accurate and repeatable system of making pericardial valves in which sheets or pieces of pericardium material are held securely in place relative to each other throughout all of the steps of making the valve. In addition, the methods of the present invention include maintaining consistent alignment of the fixtures and pericardium material throughout the valve assembly process and utilize features that make the tooling components easy to assemble and handle. Certain aspects of the invention can be used to help establish a repeatable sewing and cutting technique for creating a pattern shape for valve leaflets, establishing stitch lengths, and determining the exact placement of stitches.


In one aspect of the invention, a method is provided to secure two pieces of tissue material to each other in a predetermined series of vertical segments connected by arches or arcuate portions that will make up multiple leaflets of a valve. Once the tissue layers are secured to each other in a desired configuration, the tissue assembly can be formed into a tube so that the arches and vertical segments make the leaflets of a valve. The valve can then be secured to a stent to make a stented valve, if desired. In such a configuration, the stent structure may be compressible and expandable to facilitate percutaneous insertion into the heart of a patient, such as with a self-expanding stent or with a stent that is expandable when subjected to outward radial force.


In another aspect of the invention, individual leaflets are constructed, which can then be made into a multi-leaflet valve that will have more than one side seam when assembled into a tubular valve. The leaflets are each constructed from a wall layer of tissue and a leaflet layer of tissue and again are assembled in a way that involves repeatable sewing techniques for creating consistently shaped valve leaflets.





BRIEF DESCRIPTION OF THE DRAWINGS

The present invention will be further explained with reference to the appended Figures, wherein like structure is referred to by like numerals throughout the several views, and wherein: The present invention will be further explained with reference to the appended Figures, wherein like structure is referred to by like numerals throughout the several views, and wherein:



FIG. 1 is a top view of a top plate of a sewing fixture frame, in accordance with one aspect of the invention;



FIG. 2 is a top view of a sewing fixture template;



FIG. 3 is a top view of a bottom plate of a sewing fixture frame;



FIG. 4 is a top view of a final seam sewing fixture template;



FIG. 5 is a top view of a cutting fixture top plate;



FIG. 6 is a top view of an upper cutting fixture middle plate;



FIG. 7 is a top view of a lower cutting fixture middle plate;



FIG. 8 is a top view of a bottom plate of a final seam sewing fixture;



FIG. 9 is a top view of a top plate of a final seam sewing fixture;



FIG. 10 is an exploded perspective view of multiple components and material layers involved in an initial sewing step for assembling a pericardial valve;



FIG. 11 is an exploded perspective view of multiple components and material layers involved in a cutting step for assembling a pericardial valve;



FIG. 12 is an exploded perspective view of multiple components and material layers involved in a final seam sewing step for assembly a pericardial valve;



FIG. 13 is a top view of a sewing plate used for individual leaflet construction in accordance with another aspect of the invention;



FIG. 14 is a top view of a wall protection plate;



FIGS. 15 and 16 are top views of free margin cutting plates;



FIG. 17 is a top view of a sewing plate for 3-dimensional leaflets;



FIG. 18 is a perspective view of a 3-dimensional insert used for leaflet formation; and



FIG. 19 is a top view of a side seam plate;



FIG. 20 is a perspective view of a valve assembly system in accordance with the invention;



FIG. 21 is an exploded perspective view of the valve assembly system of FIG. 20;



FIG. 22 is a perspective view of a bottom plate of the valve assembly system of FIGS. 20 and 21; and



FIG. 23 is a bottom view of a top plate of the valve assembly system of FIGS. 20 and 21.





DETAILED DESCRIPTION

Heart valves made using the methods and processes of the invention can be used for replacement of pulmonary valves, aortic valves, mitral valves, or tricuspid valves, in accordance with the methods and valve constructions of the invention described herein. Alternatively, the valves of the invention can be used to replace a failed bioprosthesis, such as in the area of an aortic valve or mitral valve, for example. The shape, size, material, and configuration of the outer tubular portion of the heart valves described herein can specifically be designed and chosen for the type of valve that is being produced. The valves of the invention can include stented or stentless valves, but in either case, the valves are preferably compressible to a reduced diameter during the implantation process, such as transcatheter implantation, and can be capable of being expanded to a larger diameter once they are in their desired implantation location. The valve assemblies can be used as a surgical sutureless or apical implant, and can be utilized in percutaneous replacement of cardiac valves, for example. One exemplary method for assembling a stented valve of the invention generally includes the manufacture and preparation of a valve segment, then a subsequent mounting or attachment of the prepared valve segment to a stent.


Referring now to the Figures, wherein the components are labeled with like numerals throughout the several Figures, and initially to FIGS. 1-9, a number of tooling components are illustrated that are used in accordance with the processes and methods of the invention for assembly of a pericardial valve. In particular, FIG. 1 is a top view of a top plate 10 of a sewing fixture frame, in accordance with one aspect of the invention. Top plate 10 includes a central opening 12 through which an exemplary stitching pattern 14 is visible, such as can be provided by a sewing fixture template, as described below. The central opening 12 can be configured differently than shown, but should be small enough that the surrounding portions of the plate 10 provide enough material to securely hold tissue below it (i.e., to maximize the surface area of the plate that will be available to contact tissue), but should also be large enough to allow an operator to easily access the layers below it for sewing of tissue layers. The top plate 10 also includes at least one locating hole 16, each of which is positioned and sized for engagement with a locating pin of a bottom plate of a sewing fixture frame. This embodiment provides one locating hole 16 near each of the four corners of the top plate 10, although more or less locating holes 16 may be used. Top plate 10 also includes a number of additional holes located in various locations across its solid portion that can be used as tack holes for positioning the pericardial or tissue layers along with other tooling components, or for other purposes.



FIG. 2 is a top view of a sewing fixture template 20, which can be relatively thin as compared to the top plate 10. Template 20 includes a pattern 22 for sewing leaflets, which is located in generally the central area of the template. As shown, the pattern 22 can include a series of holes 24 that are spaced from each other, with adjacent holes 24 being connected by slots 26. Each hole 24 provides a location in which a needle can be pushed through the template 20 and the slots 26 provide a place for the thread or suture material to lie that extends between adjacent holes 24. The template 20 preferably also includes locating holes 25 that will align with the locating pins of a bottom plate of a sewing fixture frame in the processes of the invention. Template 20 also includes a number of additional holes located in various locations on its planar surface that can be used as tack holes for positioning the pericardial or tissue layers along with other tooling components, or for other purposes. At least some of these holes can correspond with holes of other plates or components of the invention, if desired.


The shaped portion of the pattern 22 includes vertical components 27 that correspond to leaflet commissures. The vertical components 27 are provided in pairs, where each vertical component 27 of a pair is spaced from the other vertical component 27 of the pair by a distance that represents the desired width of a leaflet. An arcuate portion 28 is also provided for each pair of vertical components 27, which extends between each pair of vertical components 27. The vertical components 27 are generally linear and are preferably also generally parallel to each other. Alternatively, the vertical components 27 can be arranged in a non-parallel configuration to provide another shape to the attachment pattern, such as a funnel shape, for example. The length of the vertical components 27 can be chosen to correspond to the desired depth of a leaflet, such that a pattern including relatively long vertical components 27 will provide bigger or deeper leaflets than a pattern having relatively short vertical components 27. Thus, the length of the vertical components 27 can advantageously be designed and/or selected to correspond with a desired depth of the leaflets, which selection is not available when using a native valve, for example. In any case, all of the vertical components 27 of a particular pattern 22 can have the same or nearly the same length in order to create leaflets that are identically or nearly identically shaped and sized for a certain valve. In that respect, all of the vertical components 27 can also be spaced at the same distance from each other, and also can be spaced at a distance from a corresponding edge that will facilitate making the width of all of the shaped portions the same for a particular piece of pericardium material. However, it is also contemplated that the vertical components 27 within a single valve configuration can have different lengths and/or can be spaced at different distances from each other in order to create a valve having leaflets that are not all identically sized and/or shaped.



FIG. 3 is a top view of a bottom plate 30 of a sewing fixture frame. Bottom plate 30 includes a central opening 32 through which an exemplary stitching pattern (e.g., pattern 22) is visible. The opening 32 can generally match the opening 12 of the top plate 10, or the central opening 32 of this bottom plate 30 can be different from the central opening 12 of the top plate 10. As described above relative to the opening 12 of top plate 10, the central opening 32 of bottom plate 30 can be configured differently than shown, but should be small enough that the surrounding portions of the plate 30 can securely hold tissue adjacent to it. The opening 32 also should be large enough to allow the operator to easily access the material and/or template layers that are adjacent to it. The bottom plate 30 also includes at least one locating pin 34 extending from one of its surfaces, where this embodiment provides one locating pin 34 near each of the four corners of the bottom plate 30, although more or less locating pins 34 may be used. Bottom plate 30 also includes a number of holes located in various locations across its solid portion that can be used as tack holes for positioning the pericardial or tissue layers along with other tooling components, or for other purposes.



FIG. 4 is a top view of a final seam sewing fixture template 40, which includes a stitch pattern line 42 and a reference tab window 44. An exemplary sewing pattern is superimposed on top of this template 40 for illustrative purposes. As shown, the stitch pattern line 42 can include a series of holes 46 that are spaced from each other, with adjacent holes 46 being connected by slots 48. Each hole 46 provides a location in which a needle can be pushed through the materials, and the slots 48 provide a place for the thread or suture material to lie that extends between adjacent holes 46. Template 40 also includes a number of holes located in various locations across its solid portion that can be used as tack holes for positioning the pericardial or tissue layers along with other tooling components, or for other purposes. As will be described below, it is preferable that a first sewing fixture template 40 is positioned above the layers of pericardial tissue, and that a second sewing fixture template 40 is positioned below the layers of pericardial tissue during the sewing process.



FIG. 5 is a top view of a cutting fixture top plate 50, which includes a central opening 52 that can be used as a guide during the step of cutting layers of pericardial material that are sewn together in a stitching pattern, such as the pattern 22 described above. The central opening 52 can be configured differently than shown, but should be small enough that the surrounding portions of the plate 50 can securely hold tissue below it, but should also be large enough to allow the operator to easily access the layers below it. The top plate 50 also includes at least one locating hole 54, each of which is positioned and sized for engagement with a locating pin of a bottom plate of a sewing fixture frame. This embodiment provides one locating hole 54 near each of the four corners of the top plate 50, although more or less locating holes 54 may be used. Top plate 50 also includes a number of additional holes located in various locations across its solid portion that can be used as tack holes for positioning the pericardial or tissue layers along with other tooling components, or for other purposes.



FIG. 6 is a top view of an upper cutting fixture middle plate 60, which is used in the cutting assembly and process as a spacer to keep a consistent relative thickness for the overall tooling stack. In particular, because a lower cutting fixture middle plate 70 of FIG. 7 will only extend across a portion of the width of the assembly (see FIG. 11), the plate 60 is positioned in the area across which the plate 70 does not extend in order to keep the thickness of the multiple tooling layers consistent within the assembly. Both plates 60, 70 have at least one locating hole 62, 72, respectively, that will each preferably be aligned with a locating pin during the cutting process, and can also include a number of additional holes located in various locations that can be used as tack holes for positioning the pericardial or tissue layers along with other tooling components, or for other purposes. As shown, plate 70 is also provided with scalloped portions 74 that are provided to generally match the shape of the pattern that has been sewn in the perioardial tissue. The material that makes up the plate 70 is preferably: (1) thin enough to cause only minimal displacement of the tissue layers relative to each other; (2) strong enough to withstand the action of a cutting mechanism; and (3) soft enough to not dull or otherwise adversely affect a cutting mechanism that contacts it.



FIGS. 8 and 9 are top views of a bottom plate 80 of a final seam sewing fixture and a top plate 90 of a final seam sewing fixture, respectively, with an exemplary stitching pattern superimposed on each for purposes of illustration. These plates 80, 90 are used in the final step of sewing the pericardial material into a tube, or sewing the seam, as will be described in further detail below. Bottom plate 80 further includes at least one locating pin 82, and preferably includes at least two locating pins, as shown in FIG. 12. Plate 90 preferably also includes locating holes 92 in positions that correspond with the locating pins 82 for engagement with these locating pins. As with many of the other tooling fixtures described, the plates 80, 90 can include a number of additional holes located in various locations that can be used as tack holes for positioning the pericardial or tissue layers along with other tooling components, or for other purposes.



FIG. 10 is an exploded perspective view of multiple components and tissues involved in an initial sewing step for assembling a pericardial valve, utilizing some of the components described above relative to FIGS. 1-9. In particular, two layers of pericardial material or tissue 100, 102 are positioned as layers of an assembly including a number of plates and fixtures. In accordance with one embodiment of the invention, the layers of material 100, 102 can be a relatively flat sheet of pericardium material or tissue, which may be obtained, for example, from around a porcine heart. It is understood that other donor species may alternatively be used, or that the material used may instead be a different type of tissue or material, such as a polymer or bio-engineered film.


Any pericardium material used may be at least partially fixed or cross-linked with a buffered gluteraldehyde solution or other solution at some point during the assembly process, in order to make the material easier for an operator to handle and manipulate. In one specific example, a piece of porcine pericardium is obtained, which is rinsed for approximately 10 minutes in a buffered gluteraldehyde solution to partially cross-link the material. U.S. Pat. No. 4,976,733 (Girardot), titled “Prevention of Prosthesis Calcification”, describes a variety of additional exemplary methods of treating pericardium material that may be useful with the systems and methods of the present invention, along with methods for retarding or preventing the calcification of a prosthesis implanted in a mammal. However, such treatments to the material are optional and may be different depending on operator preference, the material chosen, and the like. The piece of pericardium can then be cut to a predetermined shape and size, such as the rectangular pieces of pericardium material 100, 102 illustrated in FIG. 10. If the material is thicker than desired, the thickness can be reduced using any of a number of available methods for effectively removing some of the thickness of the pericardium material without sacrificing an undesirable amount of the strength of the material. The sheets of material 100, 102 can also be provided with locating holes 104 that preferably will align with the locating pins 34 of the bottom plate 30 of the sewing fixture frame.


The description of the positioning of the tooling components and tissue of an assembly are described herein as having “top” and “bottom” components, which generally corresponds to the figures. However, these terms are used for description purposes and are meant to describe the relative positioning of the components in an assembly. That is, the components could alternatively be reversed so that the top plate of the sewing fixture frame is actually on the bottom of the assembly, for example. Referring again to FIG. 10, a first sewing fixture template 20 is positioned on the top of the tissue layers 100, 102, while a second sewing fixture template 20 is positioned below the tissue layers 100, 102. A top plate 10 of the sewing fixture frame is positioned on top of the first sewing fixture template 20. A bottom plate 30 of the sewing fixture frame is positioned below the second sewing fixture template 20. All of the components, including the tissue layers, are preferably aligned so that the locating pins 34 of the bottom plate 30 of the sewing fixture frame can extend through their respective locating holes. The various additional holes in the components can be used as tack holes to help keep the tissue layers from sliding relative to each other. In that regard, a number of materials can be used for tacking, including pins, sutures, magnets, mechanical clamps, O-rings, or any other material or components that will exert adequate pressure or attachment features to keep the tissue layers 100, 102 from moving relative to each other. For case in accurate assembly of the components, some or all of the tooling components can be at least partially transparent or opaque so that adjacent layers or components are visible or partially visible through some or all of the components.


After all of the components are assembled, an operator or an automated or semi-automated machine can stitch the layers of tissue 100, 102 to each other along the stitch pattern of the sewing fixture templates. The top plate 10 of the sewing fixture frame and the first (top) sewing fixture template 20 are then removed. A lower cutting fixture middle plate 70 is then inserted between the layers of tissue as shown in FIG. 11, and an upper cutting fixture middle plate 60 (which can also be referred to as a “spacer plate”) is positioned on top of the upper layer of tissue 100. Alternatively, this upper cutting fixture middle plate 60, or spacer plate, can be inserted between the layers of tissue 100, 102, on the opposite side of the tissue layer from the lower cutting fixture middle plate 70. A top plate 50 of a cutting fixture is then placed on top of the assembly. This top plate 50 is used to define the free margin of the valve assembly. After the components are assembled in this way, the upper layer of tissue 100 is cut using a blade, die, stamp, or the like, by generally following the opening 52 in the top plate 50 of the cutting fixture. The placement of the lower cutting fixture middle plate 70 allows cutting of the upper layer of tissue 100 by cutting along or within the opening 52 in the top plate 50 of the cutting fixture, but protects the lower layer of tissue 102 from being cut. The components are all then disassembled, with only the stitched tissue being used in the next step of the process.


The stitched tissue assembly is then folded in half with the leaflet surface being on the inside of the fold. The locating holes 104 of the tissue layers 100, 102 should be aligned with each other after the tissue is folded to provide consistency of alignment in the final sewing step of FIG. 12. The folded tissue is then positioned as shown, with a sewing fixture template 40 adjacent to both its top and bottom sides, a bottom plate 80 of a final sewing fixture on the bottom of the assembly (with its locating pins 82 protruding upwardly), and a top plate 90 of a final sewing fixture on the top of the assembly. The locating pins 82 should extend through locating holes in the components to be sure the tissue is correctly aligned.


In this step, a reference tab of the stitched tissue should fall within the reference tab window of the final sewing fixture templates 40 (see reference tab window 44 of FIG. 4). The tissue can then be sewn along the pattern line of the final sewing fixture templates 40 to create a seam for the valve that can be considered to be a one-seam valve. It is noted that the reference tab window 44 can be different than shown (e.g, taller, shorter, differently located, and the like), as long as it is consistent for all applications. The process described above relative to FIGS. 1-12 thus provides tooling and processes for making valves in a consistent, repeatable fashion due to the securing of the tissue layers relative to each other, the alignment of features throughout the process, and other factors.


As set out above, the two thicknesses of pericardium material can be attached to each other by sewing along a predefined pattern. The suture material used for the sewing process may be provided as a monofilament or multifilament structure made of natural or synthetic material (e.g., nylon or polypropylene), or may alternatively include an elongated metal or metal-composite thread or filament that is suitable for securing layers of pericardium material to each other. The stitching and suturing techniques will typically involve using an elongated thread-like material that may be attached to a needle to perform the securing function, which may either be done by hand or with an automated machine. Referring again to FIG. 10, such techniques would typically include pushing the needle repeatedly through both thicknesses of the pericardium material in an outline shape that matches the desired pattern.



FIGS. 13-19 illustrate additional exemplary assembly sequences for making pericardial valves, including 2-dimensional leaflet construction and 3-dimensional leaflet construction. In these embodiments, individual leaflets are constructed, and several individual leaflets can be assembled into a multi-leaflet valve that has more than one side seam. Each of the constructed leaflets can be identical in size and shape to each other within a particular valve, or they can have different sizes, shapes, and/or patterns. First, with regard to a 2-dimensional leaflet construction, an assembly used for sewing includes a leaflet sewing plate on the bottom (e.g., sewing plate 160 illustrated in FIG. 13), then a wall layer of pericardial tissue, then a wall protection plate (e.g., wall protection plate 180 illustrated in FIG. 14), then a leaflet layer of pericardial tissue, then another leaflet sewing plate. In particular, the sewing plate 160 of FIG. 13 includes at least one locating hole 162, where this illustrated embodiment includes four of such locating holes in which locating pins can be placed for alignment of this plate with other components in the assembly and with the tissue layers. The sewing plate 160 further includes a number of tack holes or apertures 164, which are located generally around the perimeter of where the leaflet tissue will be positioned. There can be more or less tack holes 164 than illustrated, and they can be positioned differently than shown; however, there should be a sufficient number of tack holes 164 that can be used to help secure the tissue layers in place and prevent slippage between components during sewing.


The sewing plate 160 further includes a “margin of attachment” stitch pattern 166, which includes a series of holes 168 spaced from each other with suture channels 170 between adjacent holes 168. The holes 168 are provided as the location in which a needle will be inserted through the layers of tissue, and the channels 170 are provided for the portions of thread positioned between the holes 168. In this figure, a running stitch pattern is shown, although other stitch patterns can be used. One or more (preferably two) reference lines 172 are provided to show where the leaflet commissure will be created once the side seam is stitched in subsequent operations. Finally, at least one (preferably two) reference stitch lines 174 are provided, which include another series of holes and channels, as described above relative to other stitching patterns. The operator will use this line when stitching the “margin of attachment” stitches and will use the line with the side seam fixture to align the leaflets to each other.


The wall protection plate 180 is a plate that is positioned between two layers of pericardial tissue that are sewn together to create a leaflet. This plate 180 protects the wall tissue layer when the leaflet free margin is cut. This wall protection plate includes open slots 182 that allow the “margin of attachment” stitching and reference line stitching to go through to the wall protection plate. That is, because this plate will need to be removed from between the two layers of tissue, it cannot be sewn into the assembly. This plate is actually a two-piece assembly, as indicated by the break line 184, which allows the plate to be removed from the assembly once the layers of tissue are sewn together and the free margin is cut. The material that makes up these plate pieces is preferably: (1) thin enough to cause only a minimal gap between the two layers of tissue; (2) strong enough to withstand the cutting mechanism used to create the free margin of the leaflet; and (3) soft enough to not dull or otherwise adversely affect the free margin cutting mechanism.


Once the leaflets are sewn, such as is described above, the free margin can be cut. In order to do this, the top leaflet sewing plate is removed (i.e., the plate that is on top of the leaflet layer of pericardial tissue), and the free margin cutting plate (such as one of the cutting plates 200, 210 illustrated in FIGS. 15 and 16, respectively) is placed onto the leaflet layer of tissue. A cutting mechanism is then used to cut the designated free margin shape. Because the wall protection plate 180 is positioned between the leaflet and wall tissue, the cutting mechanism will only penetrate the leaflet layer of tissue. The channels 202, 212 illustrated in FIGS. 15 and 16, respectively, are examples of shapes that can be used for the free margin, which can be cut in any number of ways, such as by a blade, stamp, laser, or other cutting mechanism.


Next, with regard to a 3-dimensional leaflet construction, an assembly used for sewing includes a leaflet sewing plate on the bottom (e.g., sewing plate 160 illustrated in FIG. 13), then a wall layer of pericardial tissue, then a wall protection plate (e.g., wall protection plate 180 illustrated in FIG. 14), then a 3-dimensional mold (e.g., a mold or insert 220 of the type illustrated in FIG. 18), then a leaflet layer of pericardial tissue, then a 3-dimensional leaflet sewing plate (e.g., a leaflet sewing plate 240 of the type illustrated in FIG. 17). A similar sequence of steps and plate features to those described above can be followed; however, in this leaflet construction, a window is cut out of the 3-dimensional sewing plate 240 as designated by the aperture 242 to allow for a 3-dimensional insert (e.g., the insert 220 of FIG. 18) to be placed under the leaflet layer of tissue, thereby increasing the leaflet surface area while maintaining a constant wall surface area. The stitch pattern of this sewing plate, including the “margin of attachment” and reference lines, remain on a 2-dimensional plane, which is important for maintaining both a constant surface area of the wall tissue and to provide for ease in manufacturability. The mold curvature provided by the insert 220 preferably matches that of the margin of attachment and also defines the amount of tissue used to create each leaflet. It is noted that in this construction of a 3-dimensional leaflet, the free margin can be cut into the leaflet of tissue prior to sewing. In this way, the free margin cutting plate can be used to cut the tissue on a 2-dimensional plane.


In order to form or make a leaflet assembly into a cylindrical or tubular valve using 2-dimensional or 3-dimensional leaflets, its side seams can be sewn using side seam plates 260 of the type illustrated in FIG. 19. In particular, an assembly is provided with a side seam plate 260 on which a first leaflet is placed with the leaflet side up, then a second leaflet is placed on the first leaflet with the leaflet side down, and then another side seam plate is placed on top of this second leaflet. Holes 262 of the side seam plates are provided to align with holes on the leaflet construction templates, in order to maintain alignment of the components. The side seam stitch pattern 264 consists of a series of holes 266 and channels 268 as described above relative to other stitching patterns. Finally, the reference line window 270 is provided for alignment with the reference lines that were stitched in the tissue with the sewing plates. This helps ensure that the two leaflets being stitched together are in proper alignment with the side seam stitch pattern and with one another. This general sequence is repeated to create three side seams for a tri-leaflet valve.



FIGS. 20-23 illustrate an exemplary valve assembly system 300 that can be used for making pericardial valves, including 2-dimensional leaflet constructions and 3-dimensional leaflet constructions, as desired. The system 300 can tightly secure pericardial tissue or other material during the processes of sewing and cutting the material, along with maintaining tissue tension, maintaining alignment of the tissue and assembly templates, and minimizing the transfer of tissue to multiple fixtures during the assembly thereof. In this way, a repeatable sewing and cutting technique can be established for the pattern shape, stitch length, and stitch placement. In addition, the system 300 uses features that make the fixturing easy to assemble and handle by the operator.


In order to provide the features described above, the valve assembly system 300 is provided with a robust and user-friendly pinning system. This system uses concentrated areas of multiple pins along the perimeter of the fixture for holding the tissue. In addition, one embodiment of the valve assembly system is a single-frame system, which provides for easy alignment of tissue. Overall, the assembly can be relatively thin so that it is a handheld device for an operator, although it is possible that the assembly is larger such that it is instead more appropriate for tabletop usage.


Valve assembly system 300 generally includes a top plate 302, a bottom plate 304, at least one frame clamp 306, and a slide pin cover 308. Although tissue is not shown in these Figures, tissue would be held between the top plate 302 and bottom plate 304 during the valve assembly process. Sewing and cutting templates can be slid in and out of the assembly 300 without transferring the tissue to any other fixtures. In this way, once the tissue is secured between the top plate 302 and bottom plate 304, it will not need to be removed until the valve is completely sewn and assembled. Rather, pins 310 or other protrusions can extend from a top face of the bottom plate 304 to secure the tissue in place relative to the top plate 302 throughout the valve assembly process. In addition, peripheral locating pins can be used to ensure proper alignment of the tissue and templates relative to each other.


As illustrated in FIG. 23, top frame 302 may include multiple locating pin holes 316 for alignment with one or more sewing templates and the bottom plate 304. These pin holes 316 can extend through the entire thickness of the top plate 302 or only partially through its thickness. The top plate 302 may also be provided with a notch or contour 314 on one or more of its sides that can facilitate the movement of sewing and cutting templates relative to the assembly 300. The plate 302 can further include concentrated areas of holes 318 that can engage with the pins 310 that extend from the bottom plate 304. The top plate 302 may further optionally include a shelf step or recessed area (not shown) in its bottom surface that can accommodate the thickness of any sewing or cutting templates that are used.


Bottom plate 304, illustrated in FIG. 22, can also include locating pin holes 316 that can be used for alignment with sewing and/or cutting templates and the top plate 302. The plate 304 can further include concentrated areas of holes 312 on its top surface into which pins 310 can be pressed, as is illustrated in FIG. 21. These pins 310 are preferably generally perpendicular to the face of the bottom plate 304 when they are inserted into the holes 312. As with the plate 302, the bottom plate 304 may optionally include a shelf stop or recessed area (not shown) in its top surface that can accommodate the thickness of sewing and/or cutting plates. Bottom plate 304 further includes concentrated areas of holes 322 on at least one of its sides. These holes 322 may also have pins 310 inserted therein, where these pins 310 can be used for engagement with a slide pin cover 308 or other component.


One embodiment of slide pin cover 308 may include concentrated areas of holes that correspond with the pins 310 that extend from the holes 322. The assembly may further include at least one finger spring 330 that extends from one or both sides of the pin cover 308. The spring or springs 330 can be used to secure the pin cover 308 to the system 300.


System 300 further includes at least one frame clamp 306 for securing the top plate 302 to the bottom plate 304. The number of frame clamps 306 used can vary in order to achieve the desired clamping of the components to each other, but the assembly 300 preferably includes at least one clamp 306 on three of its sides. As illustrated in the embodiment of FIG. 20, the side of the system 300 that includes the slide pin cover 308 does not also have a clamp 306. In this way, any templates that are used can be slid into this side of the system. Each frame clamp 306 can include a tapered edge that allows it to slide onto the frame easily. In order to keep the components of the system stable relative to each other, the clamps 306 are preferably designed or chosen to provide a snug fit between components. However, the clamp 306 can also be relatively low profile so that the overall size of the system 300 is not increased by the clamp size.


In many of the embodiments described herein, the pericardial valve is prepared to include three leaflets, but may optionally have more or less than three leaflets, which can be formed by varying the number of leaflet and outer tube components. The three leaflet embodiment can be used in areas of the heart that typically have a three leaflet valve, such as the pulmonary valve and aortic valve, although the three leaflet embodiment can also be used as a replacement for the two leaflet mitral valve. Alternatively, a two leaflet or single leaflet embodiment of the valve of the invention is contemplated, which can be used in areas of the heart that typically have a three leaflet valve, such as the pulmonary valve, for example. Certain considerations for blood flow will determine particular parameters of the valve used.


Once a tissue valve is manufactured using the above techniques and tooling, the tissue valve can be attached within a stent, where the stent can be secured to the valve segment in a variety of ways. One procedure that can be used is to suture certain areas of the stent to the valve segment. The suture material may be provided as a monofilament or multifilament structure made of natural or synthetic materials (e.g., nylon or polypropylene), or may alternatively include an elongated metal or metal-composite thread or filament that is suitable for permanently securing the stent to the valve segment in accordance with the present invention. The number and location of suture points can vary, but should include an adequate number of connection points that are positioned in predetermined locations that prevent movement of the stent relative to the valve segment, particularly during the compression of the stent for percutaneous delivery and expansion of the stent for its deployment.


The stented valve can be subjected to suitable chemical fixation and/or bioburden reduction treatments, which may vary considerably depending on the particular requirements for storage and use of the stented valve. Chemical fixation helps to preserve the tissue, render it inert, reduce the risk of host rejection, and/or the like. Chemical fixation may occur by submerging the valve in a suitable reagent for a period of about 3 hours under slight pressure and ambient temperature and then for 72 hours under ambient pressure and temperature. By way of example, a 0.2% by weight gluteraldehyde solution at physiological pH and being phosphate buffered may be used for chemical fixation. The valve may then be stored in a suitable storage reagent (e.g., an aqueous solution containing 0.2% by weight gluteraldehyde) until subsequent use. Bioburden reduction may be carried out by submerging the tissue in a suitable reagent for a period of 48 to 72 hours at ambient temperature. By way of example, an aqueous solution containing 1% by weight gluteraldehyde and 20% by weight isopropyl alcohol at physiological pH and being phosphate-buffered may be used for bioburden reduction. This solution would be suitable for use as a packaging solution as well. A variety of fixation tines, concentrations, pH levels and chemicals can be used in accordance with the invention. After suitable treatments to the valve are complete and after appropriate rinsing of the valve, the device can be used for implantation into a human.


The stented valve may then be used with a system for delivering the valve segment to the desired location within a patient. The delivery system may include, for example, an outer sheath overlying an inner balloon catheter, where the outer sheath includes an expanded distal portion, within which the stented valve is located. The stented valve can be compressed around a single or double balloon located on the inner catheter. A tapered tip is mounted to the distal end of the inner catheter and serves to ease the passage of the delivery system through the patient's vasculature. The system also may include some type of guidewire to guide the delivery system to its desired implant location. Another alternative delivery system that can be used, in particular, for stented valves having a self-expanding stent, includes a catheter that does not have balloons, but instead includes a sheath or other mechanism that maintains the self-expanding stent in its compressed condition until it is desired to allow it to expand. When such a self-expanding stent is properly positioned in the patient, the mechanism that keeps the stent compressed can be retracted or otherwise removed to allow for expansion of the stent against the vessel walls.


The present invention has now been described with reference to several embodiments thereof. The entire disclosure of any patent or patent application identified herein is hereby incorporated by reference. The foregoing detailed description and examples have been given for clarity of understanding only. No unnecessary limitations are to be understood therefrom. It will be apparent to those skilled in the art that many changes can be made in the embodiments described without departing from the scope of the invention. Thus, the scope of the present invention should not be limited to the structures described herein, but only by the structures described by the language of the claims and the equivalents of those structures.

Claims
  • 1. An assembly for constructing a leaflet for a prosthetic valve, comprising a first leaflet sewing plate having a first surface, a first layer of material adjacent to the first surface of the first leaflet sewing plate, a wall protection plate adjacent to the first layer of material, a second layer of material adjacent to the wall protection plate, and a second leaflet sewing plate adjacent to the second layer of material, wherein the first leaflet sewing plate forms a margin of attachment stitch pattern including a series of spaced apart holes through a thickness of the first leaflet sewing plate and suture channels through a thickness of the first leaflet sewing plate, respective ones of the channels connecting adjacent ones of the holes.
  • 2. The assembly of claim 1, wherein the first leaflet sewing plate comprises at least one locating pin, and wherein each of the first layer of material, the wall protection plate, the second layer of material, and the second leaflet sewing plate comprise an aperture that is alignable with the at least one locating pin of the first leaflet sewing plate.
  • 3. The assembly of claim 1, wherein the margin of attachment stitch pattern comprises first reference stitch line spaced from a second reference stitch line and an arcuate portion extending between the first and second reference stitch lines.
  • 4. The assembly of claim 3, wherein the wall protection plate comprises open slots through which the margin of attachment stitch pattern can be accessed, and wherein the wall protection plate comprises first and second plate sections.
  • 5. The assembly of claim 1, wherein the second leaflet sewing plate forms a margin of attachment stitch pattern including a series of spaced apart holes through a thickness of the second leaflet sewing plate and suture channels through a thickness of the second leaflet sewing plate, respective ones of the channels of the second leaflet support plate connecting adjacent ones of the holes of the second leaflet sewing plate.
  • 6. The assembly of claim 5, wherein the margin of attachment stitch pattern of the first leaflet sewing plate and the margin of attachment stitch pattern of the second leaflet sewing plate are identical.
  • 7. The assembly of claim 1, wherein the wall protection plate includes first and second plate sections separable from one another at a break line, and further wherein the wall protection plate forms a slot through a thickness of the wall protection plate, the slot including a first slot segment in the first plate section and a second slot segment in the second plate section, the first and second slot segments being open to one another when the first and second plate sections are connected to one another at the break line.
CROSS-REFERENCE TO RELATED APPLICATION

The present application claims priority to U.S. Provisional Application Nos. 61/125,202, filed Apr. 23, 2008, and titled “Methods and Apparatuses for Assembly of a Pericardial Prosthetic Heart Valve” the entire contents of which is incorporated herein by reference in its entirety.

US Referenced Citations (543)
Number Name Date Kind
3657744 Ersek Apr 1972 A
3671979 Moulopoulos Jun 1972 A
3714671 Edwards et al. Feb 1973 A
3755823 Hancock Sep 1973 A
3868956 Alfidi et al. Mar 1975 A
3988993 Brophy Nov 1976 A
4035849 Angell et al. Jul 1977 A
4056854 Boretos et al. Nov 1977 A
4106129 Carpentier et al. Aug 1978 A
4222126 Boretos et al. Sep 1980 A
4265694 Boretos May 1981 A
4297749 Davis et al. Nov 1981 A
4343048 Ross et al. Aug 1982 A
4345340 Rosen Aug 1982 A
4425908 Simon Jan 1984 A
4470157 Love Sep 1984 A
4501030 Lane Feb 1985 A
4574803 Storz Mar 1986 A
4580568 Gianturco Apr 1986 A
4587910 Raines May 1986 A
4592340 Boyles Jun 1986 A
4610688 Silvestrini et al. Sep 1986 A
4639964 Binder Feb 1987 A
4647283 Carpentier et al. Mar 1987 A
4648881 Carpentier et al. Mar 1987 A
4665906 Jervis May 1987 A
4681908 Broderick et al. Jul 1987 A
4682551 Toman Jul 1987 A
4694766 Wickers et al. Sep 1987 A
4710192 Liotta et al. Dec 1987 A
4787899 Lazarus Nov 1988 A
4787901 Baykut Nov 1988 A
4796629 Grayzel Jan 1989 A
4819751 Shimada et al. Apr 1989 A
4834755 Silvestrini et al. May 1989 A
4856516 Hillstead Aug 1989 A
4872874 Taheri Oct 1989 A
4878495 Grayzel Nov 1989 A
4878906 Lindemann et al. Nov 1989 A
4883458 Shiber Nov 1989 A
4909252 Goldberger Mar 1990 A
4917102 Miller et al. Apr 1990 A
4922905 Strecker May 1990 A
4994077 Dobben Feb 1991 A
5002559 Tower Mar 1991 A
5026366 Leckrone Jun 1991 A
5032128 Alonso Jul 1991 A
5037434 Lane Aug 1991 A
5047041 Samuels Sep 1991 A
5059177 Towne et al. Oct 1991 A
5085635 Cragg Feb 1992 A
5089015 Ross Feb 1992 A
5152771 Sabbaghian et al. Oct 1992 A
5161547 Tower Nov 1992 A
5163953 Vince Nov 1992 A
5167628 Boyles Dec 1992 A
5217483 Tower Jun 1993 A
5232445 Bonzel Aug 1993 A
5272909 Nguyen et al. Dec 1993 A
5295958 Shturman Mar 1994 A
5327774 Nguyen et al. Jul 1994 A
5332402 Teitelbaum et al. Jul 1994 A
5350398 Pavcnik et al. Sep 1994 A
5370685 Stevens Dec 1994 A
5389106 Tower Feb 1995 A
5397351 Pavcnik et al. Mar 1995 A
5411552 Andersen et al. May 1995 A
5415633 Lazarus et al. May 1995 A
5431676 Dubrul et al. Jul 1995 A
5443446 Shturman Aug 1995 A
5480424 Cox Jan 1996 A
5489294 McVenes et al. Feb 1996 A
5489297 Duran Feb 1996 A
5496346 Horzewski et al. Mar 1996 A
5500014 Quijano et al. Mar 1996 A
5507767 Maeda et al. Apr 1996 A
5545209 Roberts et al. Aug 1996 A
5545211 An et al. Aug 1996 A
5545214 Stevens Aug 1996 A
5554185 Block et al. Sep 1996 A
5560309 Conley et al. Oct 1996 A
5575818 Pinchuk Nov 1996 A
5580922 Park et al. Dec 1996 A
5591195 Taheri et al. Jan 1997 A
5609626 Quijano et al. Mar 1997 A
5645559 Hachtman et al. Jul 1997 A
5667523 Bynon et al. Sep 1997 A
5674277 Freitag Oct 1997 A
5702368 Stevens et al. Dec 1997 A
5713953 Vallana et al. Feb 1998 A
5716417 Girard et al. Feb 1998 A
5746709 Rom et al. May 1998 A
5749890 Shaknovich May 1998 A
5766151 Valley et al. Jun 1998 A
5782809 Umeno et al. Jul 1998 A
5800456 Maeda et al. Sep 1998 A
5800508 Goicoechea et al. Sep 1998 A
5817126 Imran Oct 1998 A
5824041 Lenker Oct 1998 A
5824043 Cottone, Jr. Oct 1998 A
5824053 Khosravi et al. Oct 1998 A
5824056 Rosenberg Oct 1998 A
5824061 Quijano et al. Oct 1998 A
5824064 Taheri Oct 1998 A
5855597 Jayaraman Jan 1999 A
5855601 Bessler et al. Jan 1999 A
5860966 Tower Jan 1999 A
5861028 Angell Jan 1999 A
5868783 Tower Feb 1999 A
5891191 Stinson Apr 1999 A
5902937 Amrani et al. May 1999 A
5906619 Olson et al. May 1999 A
5913842 Boyd et al. Jun 1999 A
5915318 Iwasaki et al. Jun 1999 A
5925063 Khosravi Jul 1999 A
5957949 Leonhardt et al. Sep 1999 A
5968068 Dehdashtian et al. Oct 1999 A
5984957 Laptewicz, Jr. et al. Nov 1999 A
5997573 Quijano et al. Dec 1999 A
6022370 Tower Feb 2000 A
6027525 Suh et al. Feb 2000 A
6029671 Stevens et al. Feb 2000 A
6042589 Marianne Mar 2000 A
6042598 Tsugita et al. Mar 2000 A
6042607 Williamson, IV Mar 2000 A
6051104 Oriaran et al. Apr 2000 A
6059809 Amor et al. May 2000 A
6110201 Quijano et al. Aug 2000 A
6146366 Schachar Nov 2000 A
6159239 Greenhalgh Dec 2000 A
6162245 Jayaraman Dec 2000 A
6171335 Wheatley et al. Jan 2001 B1
6200336 Pavcnik et al. Mar 2001 B1
6203550 Olson Mar 2001 B1
6210408 Chandrasekaran et al. Apr 2001 B1
6218662 Tchakarov et al. Apr 2001 B1
6221006 Dubrul et al. Apr 2001 B1
6221091 Khosravi Apr 2001 B1
6245102 Jayaraman Jun 2001 B1
6248116 Chevilon Jun 2001 B1
6258114 Konya et al. Jul 2001 B1
6258115 Dubrul Jul 2001 B1
6258120 McKenzie et al. Jul 2001 B1
6277555 Duran et al. Aug 2001 B1
6299637 Shaolia et al. Oct 2001 B1
6302906 Goicoechea et al. Oct 2001 B1
6309382 Garrison et al. Oct 2001 B1
6309417 Spence et al. Oct 2001 B1
6338735 Stevens Jan 2002 B1
6348063 Yassour et al. Feb 2002 B1
6350277 Kocur Feb 2002 B1
6352708 Duran et al. Mar 2002 B1
6371970 Khosravi et al. Apr 2002 B1
6371983 Lane Apr 2002 B1
6380457 Yurek et al. Apr 2002 B1
6398807 Chouinard et al. Jun 2002 B1
6409750 Hyodoh et al. Jun 2002 B1
6425916 Garrison et al. Jul 2002 B1
6440164 DiMatteo et al. Aug 2002 B1
6454799 Schreck Sep 2002 B1
6458153 Bailey et al. Oct 2002 B1
6461382 Cao Oct 2002 B1
6475239 Campbell et al. Nov 2002 B1
6482228 Norred Nov 2002 B1
6488704 Connelly et al. Dec 2002 B1
6494909 Greenhalgh Dec 2002 B2
6503272 Duerig et al. Jan 2003 B2
6508833 Pavcnik et al. Jan 2003 B2
6527800 McGuckin, Jr. et al. Mar 2003 B1
6530949 Konya et al. Mar 2003 B2
6530952 Vesely Mar 2003 B2
6562031 Chandrasekaran et al. May 2003 B2
6562058 Seguin et al. May 2003 B2
6569196 Vesely May 2003 B1
6585758 Chouinard et al. Jul 2003 B1
6592546 Barbut et al. Jul 2003 B1
6605112 Moll et al. Aug 2003 B1
6613077 Gilligan et al. Sep 2003 B2
6622604 Chouinard et al. Sep 2003 B1
6635068 Dubrul et al. Oct 2003 B1
6652571 White et al. Nov 2003 B1
6652578 Bailey et al. Nov 2003 B2
6656213 Solem Dec 2003 B2
6673109 Cox Jan 2004 B2
6676698 McGuckin, Jr. et al. Jan 2004 B2
6682558 Tu et al. Jan 2004 B2
6682559 Myers et al. Jan 2004 B2
6685739 DiMatteo et al. Feb 2004 B2
6689144 Gerberding Feb 2004 B2
6689164 Seguin Feb 2004 B1
6692512 Jang Feb 2004 B2
6692513 Streeter et al. Feb 2004 B2
6695878 McGuckin, Jr. et al. Feb 2004 B2
6702851 Chinn et al. Mar 2004 B1
6719789 Cox Apr 2004 B2
6730118 Spenser et al. May 2004 B2
6730377 Wang May 2004 B2
6733525 Yang et al. May 2004 B2
6736846 Cox May 2004 B2
6752828 Thornton Jun 2004 B2
6769434 Liddicoat et al. Aug 2004 B2
6786925 Liddicoat et al. Sep 2004 B1
6790229 Berreklouw Sep 2004 B1
6792979 Konya et al. Sep 2004 B2
6797002 Spence Sep 2004 B2
6821297 Snyders Nov 2004 B2
6830575 Stenzel et al. Dec 2004 B2
6830584 Seguin Dec 2004 B1
6830585 Artof Dec 2004 B1
6846325 Liddicoat Jan 2005 B2
6866650 Stevens Mar 2005 B2
6872223 Roberts Mar 2005 B2
6875231 Anduiza et al. Apr 2005 B2
6883522 Spence et al. Apr 2005 B2
6887266 Williams et al. May 2005 B2
6890330 Streeter et al. May 2005 B2
6893460 Spenser et al. May 2005 B2
6896690 Lambrecht et al. May 2005 B1
6908481 Cribier Jun 2005 B2
6913600 Valley et al. Jul 2005 B2
6929653 Strecter Aug 2005 B2
6939365 Fogarty et al. Sep 2005 B1
6951571 Srivastava Oct 2005 B1
6986742 Hart et al. Jan 2006 B2
6989027 Allen et al. Jan 2006 B2
6989028 Lashinski et al. Jan 2006 B2
6991649 Sievers Jan 2006 B2
7018401 Hyodoh et al. Mar 2006 B1
7041128 McGuckin, Jr. et al. May 2006 B2
7044966 Svanidze et al. May 2006 B2
7048014 Hyodoh et al. May 2006 B2
7097659 Woolfson et al. Aug 2006 B2
7101396 Artof et al. Sep 2006 B2
7105016 Shui et al. Sep 2006 B2
7115141 Menz et al. Oct 2006 B2
7147663 Berg et al. Dec 2006 B1
7153324 Case et al. Dec 2006 B2
7160319 Chouinard et al. Jan 2007 B2
7175656 Khairkhahan Feb 2007 B2
7186265 Sharkawy et al. Mar 2007 B2
7195641 Palmaz et al. Mar 2007 B2
7198646 Figulla et al. Apr 2007 B2
7201761 Woolfson et al. Apr 2007 B2
7201772 Schwammenthal et al. Apr 2007 B2
7252682 Seguin Aug 2007 B2
7300457 Palmaz Nov 2007 B2
7300463 Liddicoat Nov 2007 B2
7316706 Bloom et al. Jan 2008 B2
7329278 Seguin Feb 2008 B2
7335218 Wilson et al. Feb 2008 B2
7338520 Bailey et al. Mar 2008 B2
7374571 Pease et al. May 2008 B2
7381218 Schreck Jun 2008 B2
7384411 Condado Jun 2008 B1
7429269 Schwammenthal et al. Sep 2008 B2
7442204 Schwammenthal et al. Oct 2008 B2
7462191 Spenser et al. Dec 2008 B2
7470284 Lambrecht et al. Dec 2008 B2
7481838 Carpentier et al. Jan 2009 B2
7544206 Cohn et al. Jun 2009 B2
7556646 Yang et al. Jul 2009 B2
7739971 Chambers et al. Jun 2010 B2
20010001314 Davison et al. May 2001 A1
20010002445 Vesely May 2001 A1
20010007956 Letac et al. Jul 2001 A1
20010010017 Letac et al. Jul 2001 A1
20010011189 Drasler et al. Aug 2001 A1
20010021872 Bailey et al. Sep 2001 A1
20010025196 Chinn et al. Sep 2001 A1
20010032013 Marton Oct 2001 A1
20010039450 Pavcnik et al. Nov 2001 A1
20010041928 Pavcnik et al. Nov 2001 A1
20010044647 Pinchuk et al. Nov 2001 A1
20020010508 Chobotov Jan 2002 A1
20020029014 Jayaraman Mar 2002 A1
20020032480 Spence et al. Mar 2002 A1
20020032481 Gabbay Mar 2002 A1
20020035396 Heath Mar 2002 A1
20020042650 Vardi et al. Apr 2002 A1
20020052651 Myers et al. May 2002 A1
20020058995 Stevens May 2002 A1
20020072789 Hackett et al. Jun 2002 A1
20020099439 Schwartz et al. Jul 2002 A1
20020103533 Langberg et al. Aug 2002 A1
20020107565 Greenhalgh Aug 2002 A1
20020111674 Chouinard et al. Aug 2002 A1
20020123802 Snyders Sep 2002 A1
20020133183 Lentz et al. Sep 2002 A1
20020138138 Yang Sep 2002 A1
20020151970 Garrison et al. Oct 2002 A1
20020161392 Dubrul Oct 2002 A1
20020161394 Macoviak et al. Oct 2002 A1
20020193871 Beyersdorf et al. Dec 2002 A1
20030014104 Cribier Jan 2003 A1
20030023300 Bailey et al. Jan 2003 A1
20030023303 Palmaz et al. Jan 2003 A1
20030028247 Cali Feb 2003 A1
20030036791 Philipp et al. Feb 2003 A1
20030040772 Hyodoh et al. Feb 2003 A1
20030040792 Gabbay Feb 2003 A1
20030050694 Yang et al. Mar 2003 A1
20030055495 Pease et al. Mar 2003 A1
20030065386 Weadock Apr 2003 A1
20030109924 Cribier Jun 2003 A1
20030125795 Pavcnik et al. Jul 2003 A1
20030130726 Thorpe et al. Jul 2003 A1
20030130729 Paniagua et al. Jul 2003 A1
20030139804 Hankh et al. Jul 2003 A1
20030149475 Hyodoh et al. Aug 2003 A1
20030149476 Damm et al. Aug 2003 A1
20030149478 Figulla et al. Aug 2003 A1
20030153974 Spenser et al. Aug 2003 A1
20030181850 Diamond et al. Sep 2003 A1
20030191519 Lombardi et al. Oct 2003 A1
20030199913 Dubrul et al. Oct 2003 A1
20030199963 Tower et al. Oct 2003 A1
20030199971 Tower et al. Oct 2003 A1
20030212410 Stenzel et al. Nov 2003 A1
20030212454 Scott et al. Nov 2003 A1
20040034411 Quijano et al. Feb 2004 A1
20040039436 Spenser et al. Feb 2004 A1
20040049224 Buehlmann et al. Mar 2004 A1
20040049262 Obermiller et al. Mar 2004 A1
20040049266 Anduiza et al. Mar 2004 A1
20040082904 Houde et al. Apr 2004 A1
20040088045 Cox May 2004 A1
20040093005 Durcan May 2004 A1
20040093060 Sequin et al. May 2004 A1
20040097788 Mourlas et al. May 2004 A1
20040098112 DiMatteo et al. May 2004 A1
20040106976 Bailey et al. Jun 2004 A1
20040106990 Spence et al. Jun 2004 A1
20040111096 Tu et al. Jun 2004 A1
20040116951 Rosengart Jun 2004 A1
20040117004 Osborne et al. Jun 2004 A1
20040122468 Yodfat et al. Jun 2004 A1
20040122516 Fogarty Jun 2004 A1
20040127979 Wilson Jul 2004 A1
20040138742 Myers et al. Jul 2004 A1
20040138743 Myers et al. Jul 2004 A1
20040153146 Lashinski et al. Aug 2004 A1
20040167573 Williamson Aug 2004 A1
20040167620 Ortiz Aug 2004 A1
20040186563 Iobbi Sep 2004 A1
20040193261 Berreklouw Sep 2004 A1
20040210240 Saint Oct 2004 A1
20040210304 Seguin et al. Oct 2004 A1
20040210307 Khairkhahan Oct 2004 A1
20040215333 Duran Oct 2004 A1
20040215339 Drasler et al. Oct 2004 A1
20040225353 McGuckin, Jr. Nov 2004 A1
20040225354 Allen Nov 2004 A1
20040254636 Flagle et al. Dec 2004 A1
20040260394 Douk et al. Dec 2004 A1
20040267357 Allen et al. Dec 2004 A1
20050010246 Streeter Jan 2005 A1
20050010285 Lambrecht et al. Jan 2005 A1
20050010287 Macoviak Jan 2005 A1
20050015112 Cohn et al. Jan 2005 A1
20050027348 Case et al. Feb 2005 A1
20050033398 Seguin Feb 2005 A1
20050043790 Seguin Feb 2005 A1
20050049692 Numamoto Mar 2005 A1
20050049696 Siess Mar 2005 A1
20050055088 Liddicoat et al. Mar 2005 A1
20050060029 Le Mar 2005 A1
20050060030 Lashinski et al. Mar 2005 A1
20050075584 Cali Apr 2005 A1
20050075712 Biancucci Apr 2005 A1
20050075717 Nguyen Apr 2005 A1
20050075719 Bergheim Apr 2005 A1
20050075724 Svanidze Apr 2005 A1
20050075727 Wheatley Apr 2005 A1
20050075730 Myers Apr 2005 A1
20050075731 Artof Apr 2005 A1
20050085841 Eversull et al. Apr 2005 A1
20050085842 Eversull et al. Apr 2005 A1
20050085843 Opolski et al. Apr 2005 A1
20050085890 Rasmussen et al. Apr 2005 A1
20050085900 Case et al. Apr 2005 A1
20050096568 Kato May 2005 A1
20050096692 Linder et al. May 2005 A1
20050096724 Stenzel et al. May 2005 A1
20050096734 Majercak et al. May 2005 A1
20050096735 Hojeibane et al. May 2005 A1
20050096736 Osse et al. May 2005 A1
20050096738 Cali et al. May 2005 A1
20050107871 Realyvasquez et al. May 2005 A1
20050113910 Paniagua May 2005 A1
20050119688 Berheim Jun 2005 A1
20050131438 Cohn Jun 2005 A1
20050137686 Salahieh Jun 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137692 Haug Jun 2005 A1
20050137695 Salahieh Jun 2005 A1
20050137701 Salahieh Jun 2005 A1
20050143809 Salahieh Jun 2005 A1
20050148997 Valley et al. Jul 2005 A1
20050149181 Eberhardt Jul 2005 A1
20050165477 Anduiza et al. Jul 2005 A1
20050187616 Realyvasquez Aug 2005 A1
20050203549 Realyvasquez Sep 2005 A1
20050203605 Dolan Sep 2005 A1
20050203618 Sharkawy Sep 2005 A1
20050222674 Paine Oct 2005 A1
20050228495 Macoviak Oct 2005 A1
20050234546 Nugent Oct 2005 A1
20050240200 Bergheim Oct 2005 A1
20050240263 Fogarty et al. Oct 2005 A1
20050261759 Lambrecht et al. Nov 2005 A1
20050283962 Boudjemline Dec 2005 A1
20060004439 Spenser et al. Jan 2006 A1
20060009841 McGuckin et al. Jan 2006 A1
20060052867 Revuelta et al. Mar 2006 A1
20060058775 Stevens et al. Mar 2006 A1
20060089711 Dolan Apr 2006 A1
20060100685 Seguin et al. May 2006 A1
20060116757 Lashinski et al. Jun 2006 A1
20060135964 Vesely Jun 2006 A1
20060142848 Gabbay Jun 2006 A1
20060167474 Bloom et al. Jul 2006 A1
20060178740 Stacchino et al. Aug 2006 A1
20060195134 Crittenden Aug 2006 A1
20060206192 Tower et al. Sep 2006 A1
20060206202 Bonhoefer et al. Sep 2006 A1
20060247763 Slater Nov 2006 A1
20060259134 Schwammenthal et al. Nov 2006 A1
20060259136 Nguyen et al. Nov 2006 A1
20060259137 Artof et al. Nov 2006 A1
20060265056 Nguyen et al. Nov 2006 A1
20060271166 Thill et al. Nov 2006 A1
20060271175 Woolfson et al. Nov 2006 A1
20060276874 Wilson et al. Dec 2006 A1
20060282161 Huynh et al. Dec 2006 A1
20070005129 Damm et al. Jan 2007 A1
20070005131 Taylor Jan 2007 A1
20070010878 Raffiee et al. Jan 2007 A1
20070016286 Herrmann et al. Jan 2007 A1
20070027518 Case et al. Feb 2007 A1
20070027533 Douk Feb 2007 A1
20070043435 Seguin et al. Feb 2007 A1
20070051377 Douk et al. Mar 2007 A1
20070073392 Heyninck-Janitz Mar 2007 A1
20070078509 Lotfy et al. Apr 2007 A1
20070078510 Ryan Apr 2007 A1
20070088431 Bourang et al. Apr 2007 A1
20070093869 Bloom et al. Apr 2007 A1
20070100439 Cangialosi May 2007 A1
20070100440 Figulla May 2007 A1
20070100449 O'Neil et al. May 2007 A1
20070112415 Bartlett May 2007 A1
20070162102 Ryan et al. Jul 2007 A1
20070162113 Sharkawy et al. Jul 2007 A1
20070185513 Woolfson et al. Aug 2007 A1
20070203391 Bloom et al. Aug 2007 A1
20070225681 House Sep 2007 A1
20070232898 Huynh et al. Oct 2007 A1
20070233228 Eberhardt et al. Oct 2007 A1
20070233237 Krivoruchko Oct 2007 A1
20070233238 Huynh et al. Oct 2007 A1
20070238979 Huynh et al. Oct 2007 A1
20070239254 Marchand et al. Oct 2007 A1
20070239265 Birdsall Oct 2007 A1
20070239266 Birdsall Oct 2007 A1
20070239269 Dolan et al. Oct 2007 A1
20070239273 Allen Oct 2007 A1
20070244544 Birdsall et al. Oct 2007 A1
20070244545 Birdsall et al. Oct 2007 A1
20070244546 Francis Oct 2007 A1
20070244553 Rafiee et al. Oct 2007 A1
20070244554 Rafiee et al. Oct 2007 A1
20070244555 Rafiee et al. Oct 2007 A1
20070244556 Rafiee et al. Oct 2007 A1
20070244557 Rafiee et al. Oct 2007 A1
20070250160 Rafiee Oct 2007 A1
20070255394 Ryan Nov 2007 A1
20070255396 Douk et al. Nov 2007 A1
20070288000 Bonan Dec 2007 A1
20080004688 Spenser et al. Jan 2008 A1
20080004696 Vesely Jan 2008 A1
20080006501 Haupt et al. Jan 2008 A1
20080009940 Cribier Jan 2008 A1
20080015671 Bonhoeffer Jan 2008 A1
20080021552 Gabbay Jan 2008 A1
20080048656 Tan Feb 2008 A1
20080065206 Liddicoat Mar 2008 A1
20080071361 Tuval et al. Mar 2008 A1
20080071362 Tuval et al. Mar 2008 A1
20080071363 Tuval et al. Mar 2008 A1
20080071366 Tuval et al. Mar 2008 A1
20080071368 Tuval et al. Mar 2008 A1
20080077234 Styrc Mar 2008 A1
20080082165 Wilson et al. Apr 2008 A1
20080082166 Styrc et al. Apr 2008 A1
20080133003 Seguin et al. Jun 2008 A1
20080140189 Nguyen et al. Jun 2008 A1
20080147105 Wilson et al. Jun 2008 A1
20080147180 Ghione et al. Jun 2008 A1
20080147181 Ghione et al. Jun 2008 A1
20080147182 Righini et al. Jun 2008 A1
20080154356 Obermiller et al. Jun 2008 A1
20080161910 Revuelta et al. Jul 2008 A1
20080161911 Revuelta et al. Jul 2008 A1
20080183273 Mesana et al. Jul 2008 A1
20080188928 Salahieh et al. Aug 2008 A1
20080215143 Seguin et al. Sep 2008 A1
20080215144 Ryan et al. Sep 2008 A1
20080228254 Ryan Sep 2008 A1
20080228263 Ryan Sep 2008 A1
20080234797 Styrc Sep 2008 A1
20080243246 Ryan et al. Oct 2008 A1
20080255651 Dwork Oct 2008 A1
20080255660 Guyenot et al. Oct 2008 A1
20080255661 Straubinger et al. Oct 2008 A1
20080262593 Ryan et al. Oct 2008 A1
20090005863 Goetz et al. Jan 2009 A1
20090012600 Styrc et al. Jan 2009 A1
20090048656 Wen Feb 2009 A1
20090054976 Tuval et al. Feb 2009 A1
20090069886 Suri et al. Mar 2009 A1
20090069887 Righini et al. Mar 2009 A1
20090069889 Suri et al. Mar 2009 A1
20090138079 Tuval et al. May 2009 A1
20090164004 Cohn Jun 2009 A1
20090171447 VonSegesser et al. Jul 2009 A1
20090192585 Bloom et al. Jul 2009 A1
20090192586 Tabor et al. Jul 2009 A1
20090192591 Ryan et al. Jul 2009 A1
20090198316 Laske et al. Aug 2009 A1
20090216310 Straubinger et al. Aug 2009 A1
20090216312 Straubinger et al. Aug 2009 A1
20090216313 Straubinger et al. Aug 2009 A1
20090240264 Tuval et al. Sep 2009 A1
20090240320 Tuval Sep 2009 A1
20090287299 Tabor et al. Nov 2009 A1
20100011564 Millwee et al. Jan 2010 A1
20100018447 Holecek et al. Jan 2010 A1
20100023120 Holecek et al. Jan 2010 A1
20100036484 Hariton et al. Feb 2010 A1
20100094411 Tuval et al. Apr 2010 A1
20100100167 Bortlein et al. Apr 2010 A1
20100131054 Tuval et al. May 2010 A1
20100137979 Tuval et al. Jun 2010 A1
Foreign Referenced Citations (66)
Number Date Country
2007-100074433 Aug 2007 CN
195 32 846 Mar 1997 DE
195 46 692 Jun 1997 DE
195 46 692 Jun 1997 DE
198 57 887 Jul 2000 DE
199 07 646 Aug 2000 DE
100 48 814 Sep 2000 DE
100 49 812 Apr 2002 DE
100 49 813 Apr 2002 DE
100 49 815 Apr 2002 DE
0103546 Mar 1984 EP
0597967 Dec 1994 EP
0850607 Jul 1998 EP
1057459 Jun 2000 EP
1057460 Jun 2000 EP
1088529 Apr 2001 EP
1255510 Nov 2002 EP
0937439 Sep 2003 EP
1340473 Sep 2003 EP
0819013 Jun 2004 EP
2788217 Dec 1999 FR
2056023 Mar 1981 GB
2433700 Dec 2007 GB
9529640 Nov 1995 WO
9814137 Apr 1998 WO
9829057 Jul 1998 WO
9933414 Jul 1999 WO
0041652 Jul 2000 WO
0044313 Aug 2000 WO
0047136 Aug 2000 WO
0047139 Aug 2000 WO
0135870 May 2001 WO
0149213 Jul 2001 WO
0154625 Aug 2001 WO
0162189 Aug 2001 WO
0164137 Sep 2001 WO
0176510 Oct 2001 WO
0222054 Mar 2002 WO
0236048 May 2002 WO
0241789 May 2002 WO
0243620 Jun 2002 WO
0247575 Jun 2002 WO
0249540 Jun 2002 WO
03003943 Jan 2003 WO
03003949 Jan 2003 WO
03011195 Feb 2003 WO
03030776 Apr 2003 WO
2004019811 Mar 2004 WO
2004019825 Mar 2004 WO
2004023980 Mar 2004 WO
2004041126 May 2004 WO
2004058106 Jul 2004 WO
2004089250 Oct 2004 WO
2005004753 Jan 2005 WO
2005027790 Mar 2005 WO
2005046528 May 2005 WO
2008047354 Apr 2008 WO
2008079962 Jul 2008 WO
2008100599 Aug 2008 WO
2008150529 Dec 2008 WO
2009002548 Dec 2008 WO
2009029199 Mar 2009 WO
2009042196 Apr 2009 WO
2009045338 Apr 2009 WO
2009061389 May 2009 WO
2009091509 Jul 2009 WO
Related Publications (1)
Number Date Country
20100018447 A1 Jan 2010 US
Provisional Applications (1)
Number Date Country
61125202 Apr 2008 US